
Galina Marder MD Director, Vasculitis and Myositis Center
Lupus & Related, Myositis, Vasculitis
Professor of Medicine, Zucker SOM at Hofstra/Northwell
Join to View Full Profile
865 Northern BoulevardSuite 302Great Neck, NY 11021
Phone+1 516-708-2550
Fax+1 516-708-2597
Dr. Marder is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Galina Marder is a rheumatologist based in Great Neck, NY, specializing in lupus, myositis, and vasculitis. She completed her fellowship in rheumatology at NYU Grossman School of Medicine and her residency in internal medicine at Zucker School of Medicine at Hofstra/Northwell at Forest Hills Hospital. Since 2012, she has served as a Director of Myositis and Vasculitis Center at Northwell Health. Dr. Marder has expertise in all forms of vasculitis and related rare diseases, inflammatory myopathies (IIM) and SLE. Her recent publications span topics such as IIM, Myositis associated interstitial lung disease and results of various clinical trials in myositis and vasculitis.
Education & Training
NYU Grossman School of MedicineFellowship, Rheumatology, 1997 - 1999
Zucker School of Medicine at Hofstra/Northwell at Forest Hills HospitalResidency, Internal Medicine, 1994 - 1997
Novosibirsk State Medical AcademyClass of 1987
Certifications & Licensure
NY State Medical License 1997 - 2026
American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR (Complete), Allscripts, 2014-2017
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR (Complete), Allscripts, 2014-2017
- CMS Meaningful Use Stage 2 Certification Allscripts TouchWorks EHR (Complete), Allscripts, 2014-2017
Clinical Trials
- Belimumab in Idiopathic Inflammatory Myositis Start of enrollment: 2015 Jan 01
Publications & Presentations
PubMed
- A Phase 3 Trial of Brepocitinib in Dermatomyositis.Ruth Ann Vleugels, Julie J Paik, Iazsmin Bauer Ventura, Aaron R Mangold, Prateek C Gandiga
The New England Journal of Medicine. 2026-05-14 - 4 citationsAbatacept for the treatment of myositis-associated interstitial lung disease.Rohit Aggarwal, Nantakarn Pongtarakulpanit, Daniel I Sullivan, Siamak Moghadam-Kia, Sangmee Sharon Bae
Rheumatology. 2025-12-01 - 2 citationsAssociations between 6-minute walk distance and physiologic measures and clinical outcomes in myositis-associated interstitial lung disease.Sangmee Sharon Bae, Daniela Markovic, Didem Saygin, Daniel Sullivan, Koichi Yamaguchi
Rheumatology. 2025-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









